Live Analyst Rating Changes 1619 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Michael Nedelcovych
TD
Michael Nedelcovych
TD Cowen
Wall Street Analyst
★★★☆☆
#1047
on 13Foresight · ranked by our own returns
50%
Success Rate
-0.1%
Average Return
3 of 6 calls profitable · -8.4% vs benchmark
📈 Across the calls we could measure, roughly 50% of Michael Nedelcovych's ratings turned a profit when each position was held for 1 year — averaging -0.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

26 Buy 5 Hold 0 Sell
Michael's Stock Coverage 10 ratings · 2026-06-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
TAK
Takeda Pharmaceutical Company
 Jun 04, 2026 BUY Strong Buy
+19.9% avg upside
5 analysts
$21.00
34.33% Upside
 ·
JNJ
Johnson & Johnson
 May 29, 2026 BUY Strong Buy
-3.5% avg upside
36 analysts
$250.00
9.47% Upside
 +1.4%
CHRS
Coherus Biosciences
 May 28, 2026 BUY Buy
+748.3% avg upside
18 analysts
 — -10.3%
RPRX
Royalty Pharma
 May 06, 2026 BUY Strong Buy
+4.2% avg upside
15 analysts
$50.00
5.58% Downside
 +6.3%
TSE:BHC
Bausch Health Companies
 Apr 30, 2026 HOLD Buy
+810.2% avg upside
29 analysts
$9.91
50.87% Upside
 ·
CH:MOLN
Molecular Partners AG
 Mar 16, 2026 BUY Strong Buy
+573.2% avg upside
5 analysts
$15.00
385.51% Upside
 ·
NVO
Novo Nordisk
 Mar 09, 2026 HOLD Hold
+168.5% avg upside
26 analysts
$42.00
2.66% Downside
 +13.4%
JP:4502
Takeda Pharmaceutical Co
 May 21, 2025 BUY Strong Buy
+6.7% avg upside
8 analysts
$5135.00
4.01% Upside
 ·
MOLN
Molecular Partners
 Mar 14, 2025 BUY Strong Buy
+161.8% avg upside
7 analysts
$17.00
345.11% Upside
 -2.5%
JP:4568
Daiichi Sankyo Company
 Sep 09, 2024 BUY Strong Buy
+74.4% avg upside
7 analysts
$6550.00
157.71% Upside
 ·
🔒 5 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Michael Nedelcovych — Frequently Asked Questions
How accurate are Michael Nedelcovych's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Michael's ratings were profitable over a one-year hold, with an average return of -0.1% per rating, or -8.4% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Michael ranked on 13Foresight?
Michael Nedelcovych is currently ranked #1047 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Michael cover?
Michael most recently has ratings on TAK, JNJ, CHRS, RPRX, TSE:BHC, CH:MOLN, NVO, JP:4502, MOLN, JP:4568. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.